Within the mammalian genome, there are many multimember gene families that encode membrane proteins with extracellular leucine rich repeats which are thought to act as cell adhesion or signalling molecules. We previously showed that the members of the NLRR gene family are expressed in a developmentally restricted manner in the mouse with NLRR-1 being expressed in the developing myotome. The FLRT gene family shows a similar genomic layout and predicted protein secondary structure to the NLRRs so we analysed expression of the three FLRT genes during mouse development. FLRTs are glycosylated membrane proteins expressed at the cell surface which localise in a homophilic manner to cell-cell contacts expressing the focal adhesion marker vinculin. Each member of the FLRT family has a distinct, highly regulated expression pattern, as was seen for the NLRR family. FLRT3 has a provocative expression pattern during somite development being expressed in regions of the somite where muscle precursor cells migrate from the dermomyotome and move into the myotome, and later in myotomal precursors destined to migrate towards their final destination, for example, those that form the ventral body wall. FLRT3 is also expressed at the midbrain/hindbrain boundary and in the apical ectodermal ridge, regions where FGF signalling is known to be important, suggesting that the role for FLRT3 in FGF signalling identified in Xenopus is conserved in mammals. FLRT1 is expressed at brain compartmental boundaries and FLRT2 is expressed in a subset of the sclerotome, adjacent to the region that forms the syndetome, suggesting that interaction with FGF signalling may be a general property of FLRT proteins. We confirmed this by showing that all FLRTs can interact with FGFR1 and FLRTs can be induced by the activation of FGF signalling by FGF-2. We conclude that FLRT proteins act as regulators of FGF signalling, being induced by the signal and then able to interact with the signalling receptor, in many tissues during mouse embryogenesis. This process may, in part, be dependent on homophilic intercellular interactions between FLRT molecules.
Introduction
Leucine rich repeats (LRRs) are a conserved hydrophobic repeat structure of approximately 24 amino acids. They are present in proteins of all organisms and of diverse function that can be located inside the cell, associated with cell membranes or in the extracellular space (Kobe and Deisenhofer, 1995) . Advances in the understanding of LRR structure have shown that the repeated leucine motifs form a structural framework that provides a concave molecular surface for protein interaction (Kobe and Kajava, 2001 ). The protein interaction occurs through amino acid side chains distributed throughout the LRR so it is thought they can interact with proteins of diverse structure. However, relatively little is known about the proteins that interact with specific LRRs.
Many membrane localised proteins contain leucine rich repeats in their extracellular regions suggesting that they may be involved in mediating cell signalling or adhesion through interaction with surrounding cells, the extracellular matrix or extracellular ligands (Buchanan and Gay, 1996) . These proteins vary in the number of repeats, the presence of other extracellular domains and their method of anchorage to the membrane. They often fall into multiple member families that have common secondary structures (Musacchio and Perrimon, 1996; Lacy et al., 1999; Nagasawa et al., 1999; Carim-Todd et al., 2003; Kuja-Panula et al., 2003; Lauren et al., 2003; Hamano et al., 2004; Haines et al., 2005) suggesting that they have undergone evolutionary gene expansion. Many of these proteins are expressed in the nervous system with several LRR membrane proteins implicated in axon guidance and cell movement. In Drosophila homophilic interaction of connectin molecules is implicated in neuromuscular target recognition (Nose et al., 1997) and the protein capricious has been implicated in neuron pathfinding and synapse formation (Shishido et al., 1998; Taniguchi et al., 2000) . The mammalian LRR containing Nogo receptor performs an important function in axon pathfinding (Fournier et al., 2001) while AMIGO family members (KujaPanula et al., 2003) and rat FLRT3 (Tsuji et al., 2004) cause increased neurite outgrowth in cell culture. Homophilic interaction has been seen between several of these proteins suggesting that they may provide a mechanism for regulating the affinity of like cells for each other (Nose et al., 1997; Kuja-Panula et al., 2003) .
The FLRT gene family was initially identified in a screen for novel extracellular matrix proteins from a human adult skeletal muscle library by screening with a degenerate oligonucleotide (Lacy et al., 1999) designed to the G2 domains of nidogen/entactin. It was shown to be a three gene family with a conserved predicted secondary structure consisting of ten leucine-rich repeats surrounded by C-terminal and N-terminal cysteine flanking regions, a fibronectin like domain, a transmembrane domain and a short intracellular tail. Their predicted secondary structure, along with the glycosylation of overexpressed FLRT protein, indicates that they are expressed at the cell surface with the extracellular leucine rich repeats available for protein-protein interaction suggesting they act as cell adhesion or signalling molecules. Rat FLRT3 (Tsuji et al., 2004; Robinson et al., 2005) and Xenopus FLRT3 (XFLRT3) (Bottcher et al., 2003) have been shown to localise to the cell surface. In adult mouse tissue all FLRT family members are expressed in the brain with additional expression for FLRT1 in the kidney, FLRT2 in the heart, skeletal muscle and pancreas, and FLRT3 in many tissues (Lacy et al., 1999) . XFLRT3 (XFLRT3) was cloned as a member of a syn-expression group with FGF8 and was shown to be a modulator of FGF signalling in the Xenopus embryo (Bottcher et al., 2003) . XFLRT3 interacts with the FGFR via its fibronectin like domain but could mediate FGF signalling via its intracellular domain indicating its role may involve the recruitment of intracellular signalling molecules to the cell membrane for the transduction of extracellular signals into the cell. These data suggest that FLRT genes, and other similar gene families, may not simply be modulators of cell adhesion but have the ability to interact with other proteins at the cell surface and regulate gene expression within the cell.
We have recently shown that the NLRR genes, a three member gene family with similar genomic and predicted protein structures, have a highly regulated pattern of expression during mouse development (Haines et al., 2005) . In this study, we analyse the expression of the structurally similar FLRT family of genes during mouse development. We find that each member of the three gene FLRT family has a distinct expression pattern localising to specific cell populations. FLRT1 is expressed in cells of the dorsal root ganglia, trigeminal ganglia and facioacoustic ganglia, the midbrain/hindbrain and forebrain/midbrain boundaries, the eye as well as several other defined tissues. FLRT2 is expressed in segmental stripes in a subset of the sclerotome, the cephalic mesoderm, head mesoderm and the epithelia of the body wall. FLRT3 has a provocative expression pattern during somite development being expressed in regions of the somite where muscle precursor cells migrate from the dermomyotome and move into the myotome and later in myotomal precursors destined to migrate towards their final destination. FLRT expression in the midbrain/hindbrain boundary, the apical ectodermal ridge and the developing sclerotome shows that FLRT expression in tissues known to be regulated by FGF signalling is conserved between frogs and mice. The FLRTs are glycosylated membrane proteins expressed efficiently at the cell surface that have the ability to localise to focal adhesions in a homophilic manner. They can be induced by the activation of FGF signalling and can interact with FGF receptors suggesting that they are involved in the regulation of FGF signalling in many tissues during development.
Materials and methods

FLRT cDNAs
The IMAGE clone 2236543 contained the entire FLRT1 open reading frame. cDNAs containing the complete FLRT2 and FLRT3 open reading frames were amplified from 10.5 dpc mouse embryo RNA using primers designed to mouse EST sequences identified by BLAST searching with the corresponding human FLRT sequences. FLRT2, 5′-ATGAGGGCAACCTAGGCAGA and 5′-TGTTACGTATGGCAATGCTC; FLRT3, 5′-AGTAACAGAAGCTACCTGCT and 5′-TGAAAAACGGCCTGTGCTTA. N-terminal FLAG tagged constructs were made by PCR inserting the FLAG tag one amino acid upstream of the first cysteine residue of the N-terminal cysteine flanking sequence. C-terminal HA tagged constructs were made by PCR. Expression constructs for mammalian cells were in pCDNA3.1 (Invitrogen).
Protein sequence alignments were performed using ClustalW and annotated using Boxshade available at www.ch.embnet.org.
In situ hybridisation
In situ hybridisation was performed as described by Haines et al. (2005) using the InsituPro in situ hybridisation processor (Intavis AG). Hybridisations were carried out at 69°C. Embryos were stained with 200 ng/ml Red Phos and 30 ng/ml NBT which gives lower background than BCIP/NBT.
Embryos were sectioned by embedding in agarose and cutting 70 μm sections using a vibratome. Antisense digoxygenin-labelled riboprobes were generated using 10× digoxygenin RNA labelling mix and RNA polymerases (Roche) following the manufacturer's instructions. A probe for FLRT1 was transcribed from a FLRT1 cDNA contained in the image clone 1107727, in the vector pBluescribe, by digestion with ScaI and transcription with T7 RNA polymerase (Roche). A riboprobe for FLRT2 was transcribed using T3 polymerase from a BamHI digest of the plasmid FLRT2 Pst, which was made by digesting the FLRT2 image clone 553778 with PstI and cloning the 5′ most fragment into PstI cut pBluescript II KS (Stratagene). A riboprobe for FLRT3 was transcribed using T3 polymerase from a BamHI digest of the plasmid FLRT3 Age, which was made by digesting the FLRT3 image clone 4950755 with AgeI and cloning the 5′ most fragment into XmaI cut pBluescript II KS.
FLRT protein analysis
For immunofluorescence Cos-7 cells were grown on coverslips and transfected using Fugene 6 transfection reagent (Roche) following the manufacturer's instructions. All applications were performed 48 h posttransfection. For whole cell staining cells were fixed in methanol for 2 min at − 20°C, rehydrated in PBS for 15 min and stained with a 1 in 500 dilution of anti FLAG M2 monoclonal antibody (Sigma) for 45 min in PBS containing 1% FCS and 3% BSA. Coverslips were washed 3 times for 5 min with PBST and stained with a 1 in 200 dilution of FITC conjugated anti mouse antibody (Sigma) for 45 min in PBS. Cells were washed 3 times for 5 min in PBST and mounted on glycerol or Vectastain mounting media (Vectorlabs). For staining of protein at the cell surface cells were fixed in 4% paraformaldehyde, incubated with 10 mM glycine and washed gently 3 times with PBS before staining with anti FLAG antibody. For analysis of protein movement after reaching the cell membrane cells were incubated with anti-FLAG antibody diluted 1 in 1000 in DMEM:10% FCS at 37°C for 4 h. Cells were then fixed in methanol, rehydrated and stained with FITC conjugated anti mouse antibody (1/200) as previously described. To co-stain for vinculin transfected cells were incubated with anti-FLAG antibody, fixed with methanol and then incubated with rabbit anti-vinculin antibody (Santa Cruz) diluted 1/10 in PBS containing 1% BSA. Cells were washed and stained with anti-mouse Texas red and anti-rabbit FITC secondary antibodies.
For Western blot of FLRT proteins Cos-7 cells were plated in 6 cm dishes and transfected using Fugene 6 transfection reagent. 24 h post-transfection cells were changed into fresh medium or medium containing 8 μg/ml Tunicamycin (Sigma) and lysed 48 h post-transfection by resuspension in 100 μl 1× SDS-PAGE gel loading buffer and heating at 100°C for 10 min. Protein extracts were separated by SDS-PAGE on a 15% gel and transferred to PVDF membrane (NEN Life Science). Blots were probed with anti-HA monoclonal antibody (Covance) following the manufacturer's instructions. Blots were visualised using ECL Western blotting detection reagents (Amersham).
FGF signalling analysis
Experiments were performed in the human embryonic kidney (HEK) 293T cell line. Cells were cultured and transfected as previously described (Burgar et al., 2002) . For FGF2 stimulation, media was replaced with Krebs HEPES Buffer and incubated at 37°C to serum starve. After 1 h, 20 ng/ml FGF2 was added in the presence of 10 μg/ml heparin for 10 min. Cell lysis, immunoprecipitation and Western analysis were performed as previously described (Burgar et al., 2002) . Membranes were incubated with; anti-Fc-HRPO conjugate (Pierce Biotechnology, 1:10,000), anti-HA (CR-UK, 1:1000), anti-Flg and anti-Bek for FGFR1 and FGFR2, respectively (Santa Cruz, 1:1000).
For analysis of gene expression, cells were not stimulated (0 min) or stimulated with FGF2 (30/60 min) as described above and total RNA was prepared using TRIZOL reagent (Gibco) according to the manufacturer's instructions. RT-PCR was performed using the QIAGEN Onestep RT-PCR kit on 2 μg of total RNA under the following conditions: one cycle of 30 min at 42°C, one cycle of 15 min at 95°C, followed by 30 cycles of 30 s at 94°C, 30 s at 55°C, and 1 min at 72°C. The primers used were: FLRT1, 5′-CCACACA-CACCATTGGCTAC and 5′-GCATGAGGTGTCCACAGATG; FLRT2, 5′-CTATCTGAACAACGGCAGCA and 5′-AATTGTCCGCCTTGATAACG; FLRT3, 5′-TGCAGAAGCTGGCACTAAGA and 5′-CAATCGCAGCAG-TAACCTGA; GAPDH, 5′-TGAAGGTCGGAGTCAACGGATTTGGT and 5′-CATGTGGGCCATGAGGTCCACCAC. Reaction products were resolved on a 0.8% agarose gel.
Results
FLRT genes in the mouse
To analyse the role of the leucine rich repeat transmembrane protein encoding FLRT family of genes during mouse development we isolated murine cDNAs containing the entire open reading frames of the three members of the family. The complete FLRT1 coding sequence was contained in the IMAGE clone 2236543 (accession number AY495668). The mouse FLRT2 and FLRT3 open reading frames were isolated by RT-PCR from 10.5 dpc mouse embryos (accession numbers AY495669 and AY495670, respectively) using primers designed to 5′ and 3′ EST sequence reads. Comparison of the mouse FLRT sequences showed the conserved structure of this family consisting of 10 extracellular leucine rich repeats surrounded by C-and N-terminal cysteine flanking sequences, a fibronectin domain, a transmembrane domain and a short intracellular tail (Fig. 1) . Comparison between mouse and human FLRT sequences showed very high levels of amino acid and DNA sequence conservation (Fig. 1C) . Human and mouse FLRT1 were 96% similar at the protein level, the FLRT2s 97% similar and the FLRT3s 96% similar. The predicted short intracellular tails showed regions of high conservation indicating they may contain functional elements (Fig. 1A) .
FLRT genes exhibit a conserved genomic structure in which the entire open reading frame and 3′UTR, as well as some 5′ UTR, are present in a single large exon with further small upstream exons constituting the remaining 5′UTR. This organisation has been seen for the genes encoding the structurally similar NLRR family of proteins (Haines et al., Fig. 2 . Expression of FLRT3 during mouse development. In situ hybridisation of 8 dpc (A, B), 9.5 dpc (C), 10.5 dpc (D) and 11 dpc (E) mouse embryos with a riboprobe for FLRT3. i-iii are sections of the embryo in D with the approximate planes of section shown by yellow lines. s-somites; vfb-hypothalamic region of the ventral forebrain; mhb-midbrain/hindbrain boundary; fmb-forebrain/midbrain boundary; aer-apical ectodermal ridge; gc-germ cells; hm-head mesoderm.
2005) and in the related Drosophila genes capricious and tartan (Milan et al., 2001) . Analysis of the mouse, rat and human genomes found no other genes exhibiting the FLRT protein domain structure defining the FLRTs as a three member mammalian gene family.
FLRT3 expression during development
To examine FLRT3 expression during mouse embryogenesis we performed whole-mount in situ hybridisation on mouse embryos from 8 to 11 dpc. Developmentally regulated expression was seen in a variety of tissues. At 8 dpc expression was seen in a distinct band in the developing brain ( Fig. 2A , arrowhead) and in the somites ( Figs. 2A and B) . At 9.5 dpc neural expression could be seen in the midbrain at the boundaries with the hindbrain and forebrain (Fig. 2C ). This expression was also evident at 10.5 dpc (Figs. 2D and Di) and 11 dpc (Fig. 2E) , however, expression at the midbrain/hindbrain boundary was less intense. Expression was seen at 9.5 dpc in the developing eye, in the hypothalamic region in the ventral forebrain, in the somites (Fig. 2C ) and in the migrating epithelial structure surrounding the lower region of the developing heart (Fig. 2C, arrowhead) . At 10.5 dpc, expression was seen in the eye and the head mesoderm (Fig. 2Dii) , in the migrating epithelial structure surrounding the lower heart ( Fig.  2D and Diii, arrowheads) and in the apical ectodermal ridge (Fig. 2D ). These sites of expression are consistent with FLRT3 expression in rat (Robinson et al., 2004) . At 11 dpc expression appeared in the mesoderm in the head and branchial arches, the migrating germ cells and the limb (Fig. 2E) .
The pattern of expression of FLRT3 in the somites was particularly striking (Figs. 2 and 3) . Expression was seen at 8 dpc in the earliest forming somites at the dorsal lip with expression extending ventrally along the rostral and caudal lips (Fig. 2B) . At 9.5 and 10.5 dpc, expression in the earliest somites occurred throughout the inner edge of the somitic epithelium but was stronger dorsally (Figs. 3A, B and Bi). In slightly more mature somites, expression had decreased throughout the epithelium and increased at the somitic lips (Figs. 3A, B and Bii). As the somite expanded dorso-ventrally expression was highest at the dorsal and ventral lips (Figs.  3A, B) . At 9.5 dpc somites close to the limb bud showed increased expression at the ventral lip with expression still being present at lower levels at the dorsal lip (Fig. 3A) . At 10.5 dpc, when the limb bud had formed and FLRT3 expression in the apical ectodermal ridge was apparent, strong ventral expression in interlimb somites was clear ( Fig. 3B and Biii) with loss of this expression in limb level somites and anterior trunk somites (Fig. 3B) . At 11 dpc, there was strong dermomyotomal and myotomal expression in the ventral lip at the interlimb level ( Fig. 3C and C iv) that was downregulated adjacent to both limb buds (Figs. 2E and 3C ). Tail expression occurs from the dorsal somite lips and extended ventrally along the anterior and posterior lips (Fig. 3D) .
Expression of FLRT1 and 2 during mouse development FLRT1 expression was analysed on mouse embryos from 9 to 11 dpc. Expression was initially seen at 9.5 dpc in the midbrain in a strong stripe adjacent to the midbrain/hindbrain boundary with lower level expression at the midbrain/forebrain boundary (Fig. 4A) . At 10.5 dpc, expression at the brain boundaries was still evident (Fig. 4Bi) with additional expression seen in the eye, an unidentified region in the epithelium lining the foregut (Fig. 4Bii) and in the dorsal root ganglia and the trigeminal ganglia (Fig. 4Biii) . Transverse sections through the torso at limb level revealed localised expression in cells adjacent to the urogenital ridge (Fig. 4Biii,  arrowheads) . At 11 dpc, expression continued in the dorsal root ganglia and became apparent in the facio-acoustic ganglion. Expression in the midbrain had tightly restricted to the midbrain/hindbrain boundary and expression in the foregut Fig. 4 . Expression of FLRT1 during mouse development. In situ hybridisation of 9.5 dpc (A), 10.5 dpc (B) and 11 dpc (C) mouse embryos with a riboprobe for FLRT1. i-iii are sections of the embryo in panel B with the approximate planes of section shown by yellow lines. mhb-midbrain/hindbrain boundary; fmb-forebrain/ midbrain boundary; drg-dorsal root ganglia; fg-foregut; tg-trigeminal ganglia; fa-facio acoustic ganglia. had restricted to two small patches of expression, one on the posterior edge of the third branchial arch (Fig. 4C) .
In situ hybridisation analysis of FLRT2 showed strong expression at 9.5 dpc in the cephalic mesenchyme around the ventral midbrain and strong expression in tissue posterior to the developing heart (Fig. 5A) . At 10.5 dpc, strong expression was again seen in the cephalic mesenchyme adjacent to the ventral neural vesicle (Fig. 5Bi) , as well as in mesenchymal tissue in the anterior trunk that crosses the embryo ventral to the neural tube (Fig. 5Bii) and ventral head mesoderm adjacent to the forebrain (Fig. 5B) . Strong expression was seen posterior to the developing heart in the body wall overlying the pericardial cavity (Fig. 5Biii ) and in the developing stomach (Fig. 5Biv) . At 10.5 dpc, segmental stripes of expression were seen throughout the trunk (Fig. 5B) . Sections through this region showed that this expression occurs in a group of cells that lie between the dorsal root ganglia and the dermomyotomes of the somites (Fig.  5Biii and iv) . Cross sections showed that these cells are in the posterior half of the somite indicating that they are a subset of the sclerotome (Fig. 5Bv) . At 11 dpc further expression is clear in the branchial arches, the eye and the limbs (Fig. 5C ).
FLRT proteins
From their predicted secondary structure mouse FLRT proteins are likely to be transmembrane proteins involved in cell adhesion and/or signalling. To analyse the cellular localisation of FLRT proteins expression constructs containing FLRT cDNAs with a 5′ FLAG tag directly N-terminal of the Nterminal cysteine flanking sequence were produced. When overexpressed in Cos-7 cells, these proteins were efficiently localised to the cell surface membranes as well as to perinuclear Fig. 5 . Expression of FLRT2 during mouse development. In situ hybridisation of 9.5 dpc (A), 10.5 dpc (B) and 11 dpc (C) mouse embryos with a riboprobe for FLRT3. i-v are sections of the embryo in panel B with the approximate planes of section shown by yellow lines. The anterior (A) side of section v is shown. cm-cephalic mesenchyme; tm-trunk mesenchyme; scl-sclerotome; dm-dermomyotome, nt-neural tube; bw-body wall; drg-dorsal root ganglia; st-stomach. intracellular organelles (Figs. 6A, C, E) . Staining of fixed nonpermeabilised cells showed that the predicted extracellular domain containing the 5′ FLAG tag and leucine rich repeats was expressed on the cell surface (Figs. 6B, D, F) .
A member of the similar NLRR protein family has been shown to be internalised by interaction via its intracellular domain with clathrin adapters (Fukamachi et al., 2002) . FLRT proteins have a conserved intracellular sequence so to test if this is involved in protein internalisation we analysed movement of FLRT protein at the cell surface by incubating live cells transfected with C-terminal FLAG tagged FLRT cDNAs with anti-flag antibody. No vesicular internalisation of FLRT3 was seen, however two different cellular stainings were observed (Figs. 6G and H) . Cells transfected with FLRT3 that were isolated from other FLRT positive cells showed staining that was uniformly spread throughout the cell membrane (Fig. 6G) . FLRT3 positive cells that were adjacent to other over expressing cells showed an accumulation of protein staining at the cell-cell junction (Fig. 6H) , with the amount of protein accumulated at the cell junctions correlating with a decrease in staining levels in the rest of the membrane. FLRT3 protein localised to small cell contacts where cell projections contacted adjacent cells (Fig.  6K , arrows) and also to extensive regions of contact showing a large accumulation of FLRT protein (Fig. 6K, arrowhead) . Localisation of FLRT3 at cell contacts did not occur at the junctions between FLRT3 transfected and untransfected cells (Fig. 6K, asterisk) . Identical protein localisations were seen in FLRT1 and 2 transfected cells (data not shown). To determine the properties of FLRT3 cell-cell contacts we co-stained cells transfected with FLRT3 with an antibody against vinculin, a marker for focal adhesions (Figs. 6, I-K) . Confocal analysis showed that vinculin protein localised to both large FLRT3 contacts and small FLRT3 positive contacts made by cell projections contacting an adjacent FLRT3 positive cell (Fig.  6K) . Vinculin also colocalised with FLRT1 and 2 at cell contacts (data not shown). These data indicate that when two cells expressing FLRT protein are adjacent there is active movement of these proteins to focal adhesion junctions suggesting that a homophilic intercellular recognition occurs through FLRT proteins.
To determine if FLRT proteins are glycosylated constructs containing FLRT cDNAs with a C-terminal HA tag were transfected into Cos-7 cells and resultant proteins analysed by Western blot. For each FLRT construct a band of approximately 100 kDa was seen which was reduced in size to approximately 85 kDa, the size expected for full length FLRTs, by treatment with the glycosylation inhibitor tunicamycin (Fig. 6G ). An additional band was present at approximately 20 kDa which must be liberated from the C-terminus in accordance to the location of the HA tag. The size of this band corresponds to the predicted size of a protein produced by cleavage around the transmembrane domain.
FLRTs interact with the FGF signalling pathway
In Xenopus, FLRT3 has been shown to interact with FGF receptors 1 and 4 (Bottcher et al., 2004) . The different mouse FLRT transcripts are all expressed in some tissues where FGF signalling is known to be important for their formation. To determine if mouse FLRT proteins interact with FGFR1, 3′ HA tagged FLRT cDNAs were cotransfected into 293T cells with a FGFR1 fusion construct made constitutively active by fusion to the immunoglubulin Fc domain (Burgar et al., 2002) . This construct was shown to interact with all three FLRT proteins, however, interaction with FLRT3 was not as strong as with FLRT1 and 2 (Fig. 7A) . To examine if the interaction was dependent on receptor activation we performed immunoprecipitation of cells cotransfected with FLRTs and full length receptor before or after stimulation with FGF-2 (Fig. 7B) . All FLRTs interacted with full length FGFR1 in the presence and absence of FGF-2 stimulation. The interaction with FLRT1 and 2 was stronger than with FLRT3, consistent with the data from the FGFR fusion proteins. These data show that all members of the FLRT family can interact with the FGF signalling pathway and that there may be some specificity of interaction between different FLRT members and different FGF receptors. Bottcher et al. (2004) also showed that FLRT3 expression can be induced by the activation of FGF signalling. To see if this was also true of mouse FLRT genes we stimulated 293T cells with FGF-2 and examined FLRT expression using semiquantitative RT-PCR. Before stimulation all FLRTs were expressed in 293T cells consistent with expression of FLRTs in kidney (Lacy et al., 1999, Supplementary Fig. 1 ). Upon stimulation with FGF-2, expression of all FLRT genes was induced after 30 min with the increased levels remaining after 60 min stimulation (Fig. 7C ). These data show that expression of all three mouse FLRT genes can be regulated by FGF signalling.
Discussion
In this study, we have analysed the expression of the FLRT gene family during mouse development. The three FLRT genes encode a highly conserved family of glycosylated leucine rich repeat containing membrane proteins that are expressed at the cell surface. In the mouse there is an increasing number of multi-member gene families that encode membrane proteins with extracellular leucine rich repeats (Musacchio and Perrimon, 1996; Nagasawa et al., 1999; Lacy et al., 1999; CarimTodd et al., 2003; Kuja-Panula et al., 2003; Lauren et al., 2003; Hamano et al., 2004; Haines et al., 2005) . The functions of these genes are generally not known, however, many of the proteins are expressed in the nervous system and several, including FLRT3, have been suggested to play roles in neurite outgrowth, axon guidance and synapse formation with some thought to act homophilically (Nose et al., 1997; Shishido et al., 1998; Fournier et al., 2001; Kuja-Panula et al., 2003; Robinson et al., 2004) .
FLRT3 shows a provocative expression pattern in the somites. In the early somites, expression occurs at the dorsal somitic lip on the inner edge of the dermomyotome. As the somite develops expression restricts to the dorsal and ventral lips. At the interlimb level, expression is stronger at the ventral lip with somites anterior to the forelimb showing little or no expression in the ventral lip. This expression corresponds in position and intensity to the regions of the somite where muscle precursor cells migrate from the dermomyotome and move into the myotome, or out of the myotome towards their final destination. For example, expression in the ventral lip of the earliest somites corresponds with the initial migration of myoblasts from this region into the myotome (Kalcheim et al., 1999) . Later expression in both lips corresponds to myoblast migration from both dorsal and ventral lips in the later phase of myotome development (Ordahl et al., 2000) . Strong expression of FLRT at the ventral lip of interlimb level somites corresponds with the increased migration of myoblasts associated with the formation of the trunk muscles with lack of ventral expression in limb level somites corresponding to the absence of a ventral lip. This transition involves a marked change from the epithelial morphology of the dermomyotome to the less adhesive myoblast morphology and may in part be regulated by the expression of FLRT3 at the cell surface.
Xenopus FLRT3 (XFLRT3) was identified as a gene with a similar expression pattern to FGF signalling molecules, particularly at the midbrain/hindbrain boundary (Bottcher et al., 2004) . It was shown to be regulated by FGF signalling, be able to modulate FGF signalling and to interact with the FGF receptor. Our analysis in the mouse shows FLRT expression in regions known to express FGF signalling components and in regions known to be affected by FGF signalling. Expression of FLRT1 and 3 at the midbrain/hindbrain boundary correlates with FGF expression and the role of FGFs in formation of and signalling from the isthmus (Carl and Wittbrodt, 1999; Trokovic et al., 2003) . Expression of FLRT3 in the apical ectodermal ridge co-localises with FGF expression here and the known role of FGFs in limb formation (Lewandoski et al., 2000) . Expression of FLRT3 in the somites also correlates with known sites of expression and roles for FGF signalling components (Kahane et al., 2001; Brent et al., 2003) . Expression of FLRT2 in a sub-domain of the sclerotome could provide a mechanism for regulated expression of scleraxis by FGF signalling pathways in the domain of the somitic tendon progenitors (Brent and Tabin, 2004) . Roles for FGF signalling have been suggested in dorsal root ganglia (Tanaka et al., 2001; Li et al., 2002) , various aspects of eye development (VogelHopker et al., 2000; Faber et al., 2001; Webber et al., 2003) and the cephalic mesenchyme (Mayordomo and Alvarez, 2000) , all tissues that express FLRTs. We have shown that, consistent with their expression patterns, all three mammalian FLRTs can interact with FGF receptor 1 suggesting that a role in the regulation of the FGF signalling pathway may be a generic feature of the FLRT family. Furthermore, expression of all three FLRTs can be induced by the activation of FGF signalling suggesting that they may act on the FGF receptor in a feedback mechanism.
We have shown that all three mouse FLRTs can interact with FGFR1, in a fashion that is independent of receptor activation, and Bottcher et al. (2004) showed that XFLRT3 can interact with both FGFR1 and R4. Our data indicate that there is some specificity to these interactions, as FLRT3 binds less well to FGFR1 than do the other two family members, suggesting that the various FLRTs may interact with different FGFR signalling pathways. This suggestion is supported by consideration of the available expression data. For example, FLRT1 interacts strongly with FGFR1, and both are expressed in the dorsal root ganglia (Oellig et al., 1995) while FLRT2, which shows the strongest binding to FGFR1, is co-expressed with this receptor in mesenchyme tissue (Peters et al., 1992) and in the sclerotome (Brent and Tabin, 2004) . Regulation of FGFR1 by FLRT2, which is expressed in a subset of the sclerotome, may explain why FGF-dependent scleraxis expression is confined to the syndetome (Brent and Tabin, 2004) despite the much broader expression of FGFR1. Interestingly, FLRTs interacted with a constitutively active FGFR1 containing only the transmembrane and intracellular domains fused to immunoglobulin Fc (Burgar et al., 2002) . This seems inconsistent with XFLRT3 interaction with both FGFRs through the fibronectin domain (Bottcher et al., 2004) . However, a construct of XFLRT3 containing only the transmembrane and intracellular domains was active in inducing ectopic tails in Xenopus and could interact to some extent with FGFRs (Bottcher et al., 2004) . Furthermore, a decrease in interaction was observed between FGFRs and XFLRT3 lacking a transmembrane domain (Bottcher et al., 2004) suggesting that interaction may not be restricted to the fibronectin domain. The details of how each FLRT interacts with and affects each FGF signalling pathway remain to be elucidated but their interaction and co-expression suggests that FLRTs play important roles in these pathways.
Many leucine rich repeat transmembrane proteins have been predicted to function in the nervous system with several effecting axon guidance or synapse formation (Nose et al., 1997; Shishido et al., 1998; Fournier et al., 2001; Kuja-Panula et al., 2003; Robinson et al., 2004) . The widespread expression of FLRT family members during mouse development and their interaction with FGF signalling suggests a more fundamental role. All three members of the FLRT gene family show developmentally restricted expression patterns with each FLRT gene exhibiting a distinct expression profile from the other family members. Expression of different FLRT genes occurs in groups of cells that are distinct from the surrounding cell populations. For example, FLRT1 expression in the dorsal root ganglia, FLRT2 expression in a subset of sclerotome cells and FLRT3 expression in the apical ectodermal ridge. The interaction of all FLRT molecules with FGF receptors suggests that FGF signalling may be important in the formation of all these tissues and regulation by FLRT may provide some specificity to the complex FGF signalling environment in the embryo. The observed increase in neurite outgrowth of cells overexpressing rat FLRT3 (Tsuji et al., 2004) could be explained by altered FGF signalling, with FGF-2 known to mediate neurite outgrowth in culture (Kim et al., 2003) .
When overexpressed in Cos cells FLRTs were efficiently expressed at the cell surface and localised to cell-cell contacts in a homophilic manner. Previous studies using overexpression of FLRT3 in non-adhesive cells have shown that FLRT3 cannot mediate homophilic cell adhesion (Tsuji et al., 2004; Robinson et al., 2005) . Our data suggest that FLRTs can mediate a homophilic intercellular recognition even though it may not be sufficient to confer adhesion. This is supported by Karaulanov et al. (2006) who showed that FLRTs can mediate homotypic cell sorting in 293T cells and Xenopus embryos. Some leucine rich repeat proteins with similar secondary structures to FLRTs have been shown to mediate homophilic cell adhesion (Nose et al., 1997 ; Kuja-Panula et al., 2003) but others do not (Hayata et al., 1998; Shishido et al., 1998; Tsuji et al., 2004) . The colocalisation of FLRTs to cell-cell contacts with the cytoskeletal attachment protein vinculin identifies them as focal adhesions. The details of the interactions between FGF signalling, FLRTs and focal adhesions still remain to be elucidated, however, it points further to FLRTs role in the regulation of signalling with FGFR1 shown to localise to cell adhesion contacts (Tanghetti et al., 2002) .
Other leucine rich repeat transmembrane proteins from different families have also been implicated in the regulation of cell signalling. The vasorin protein has been shown to interact with the TGF-β ligand and regulate the cellular response to TGF-β (Ikeda et al., 2004) . Kekkon 1 can inhibit EGF receptor activity (Ghiglione et al., 2003) and rat NLRR-3 may be involved in the regulation of EGF receptor signalling through an intracellular clathrin adapter interaction motif (Fukamachi et al., 2002) . These data suggest that roles for leucine rich repeat transmembrane proteins in cell signalling may be widespread.
